Preparation, characterization, and in vivo evaluation of insulin-loaded PLA–PEG microspheres for controlled parenteral drug delivery

References

• Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. (1991). Controlled delivery system for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res, 8:713–20.
   PubMed Web of Science ®Google Scholar
• D'Souza R, Mutalik S, Venkatesh M, Vidyasagar S, Udupa N. (2005). Nasal insulin gel as an alternate to parenteral insulin: Formulation, preclinical, and clinical studies. AAPS PharmSciTech, 6:E184–9.
   PubMed Web of Science ®Google Scholar
• Carino GP, Jacob JS, Mathiowitz E. (2000). Nanosphere based oral insulin delivery. J Control Release, 65:261–9.
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, Tao A, Kawashima Y. (2006). Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release, 114:242–50.
   PubMed Web of Science ®Google Scholar
• Furtado S, Abramson D, Burrill R, Olivier G, Gourd C, Bubbers E, . (2008). Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres. Int J Pharm, 347:149–55.
   PubMed Web of Science ®Google Scholar
• Toorisaka E, Hashida M, Kamiya N, Ono H, Kokazu Y, Goto M. (2005). An enteric-coated dry emulsion formulation for oral insulin delivery. J Control Release, 107:91–6.
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L, Morcol T, Bell SJD, Hickey AJ. (2003). Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSciTech, 5:1–11.
   PubMedGoogle Scholar
• Huang YY, Wang CH. (2006). Pulmonary delivery of insulin by liposomal carriers. J Control Release, 113:9–14.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T. (1999). Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release, 62:279–87.
   PubMed Web of Science ®Google Scholar
• Sahni J, Raj S, Ahmad SJ, Khar RK. (2008). Design and in vitro characterization of buccoadhesive drug delivery system of insulin. Ind J Pharm Sci, 70:61–5.
   PubMed Web of Science ®Google Scholar
• Xu HB, Huang KX, Zhu YS, Gao QH, Wu QZ, Tian WQ, . (2002). Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacol Res, 46:459–67.
   PubMed Web of Science ®Google Scholar
• Dondeti P, Zia H, Needham TE. (1995). In vivo evaluation of spray formulations of human insulin for nasal delivery. Int J Pharm, 122:91–105.
   Web of Science ®Google Scholar
• Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, . (2002). Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res, 19:998–1008.
   PubMed Web of Science ®Google Scholar
• Yu S, Zhao Y, Wu F, Zhang X, Lu W, Zhang H, . (2004). Nasal insulin delivery in the chitosan solution: In vitro and in vivo studies. Int J Pharm, 281:11–23.
   PubMed Web of Science ®Google Scholar
• Onuki Y, Morishita M, Takayama K. (2004). Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J Control Release, 97:91–9.
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhang Q, Wei S, Nagai T. (1999). Proteolytic enzymes as a limitation for pulmonary absorption of insulin: In vitro and in vivo investigations. Int J Pharm, 192:115–21.
   PubMed Web of Science ®Google Scholar
• Narayani R. (2001). Oral delivery of insulin-making needles needless. Trends Biomater Artif Organs, 15:12–6.
   Google Scholar
• Varshosaz J. (2007). Insulin delivery systems for controlling diabetes. Recent Pat Endocr Metabol Immune Drug Discov, 1:25–40.
   Google Scholar
• Sinha VR, Trehan A. (2003). Biodegradable microspheres for protein delivery. J Control Release, 90:261–80.
   PubMed Web of Science ®Google Scholar
• Furtado S, Abramson D, Simhkay L, Wobbekind D, Mathiowitz E. (2006). Subcutaneous administration of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats. Eur J Pharm Biopharm, 63:229–36.
   PubMed Web of Science ®Google Scholar
• Shenoy DB, D'Souza RJ, Tiwari SB, Udupa N. (2003). Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. Drug Dev Ind Pharm, 29:555–63.
   PubMed Web of Science ®Google Scholar
• Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. (2002). A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo. J Pharm Pharmacol, 54:1189–94.
   PubMed Web of Science ®Google Scholar
• Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. (2002). A novel sustained release formulation of insulin with dramatic reduction in initial rapid release. J Control Release, 79:81–91.
   PubMed Web of Science ®Google Scholar
• Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Kawai S, Mizushima Y, . (2004). Optimum formulation for sustained release insulin. Int J Pharm, 271:85–94.
   PubMed Web of Science ®Google Scholar
• Uchida T, Yagi A, Oda Y, Nakada Y, Goto S. (1996). Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem Pharm Bull, 44:235–6.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Takenaga M, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. (2002). Insulin loaded biodegradable PLGA microcapsules: Initial burst release controlled by hydrophilic additives. J Control Release, 81:235–49.
   PubMed Web of Science ®Google Scholar
• Hu YQ, Guo JX, Wang LJ, Tan R, Zhen LY. (2000). Preparation and evaluation of insulin-loaded polylactide microspheres using factorial design. Drug Dev Ind Pharm, 26:1309–13.
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, Ismail A, Fetouh MI, Gopferich A. (2005). Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J Control Release, 106:241–52.
   PubMed Web of Science ®Google Scholar
• Uchida T, Nagareya N, Sakakibara S, Konishi Y, Nakai A, Nishikata M, . (1997). Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method. Chem Pharm Bull, 45:1539–43.
   PubMed Web of Science ®Google Scholar
• Caliceti P, Veronese FM, Lora S. (2000). Polyphosphazene microspheres for insulin delivery. Int J Pharm, 211:57–65.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Sinha VR, Pruthi V. (2007). Preparation and characterization of poly-ε-caprolactone particles for controlled insulin delivery. J Biomed Pharm Eng, 1:40–4.
   Google Scholar
• Caliceti P, Salmaso S, Lante A, Yoshida M, Katakai R, Martellini F, . (2001). Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization. J Control Release, 75:173–81.
   PubMed Web of Science ®Google Scholar
• Cleek RL, Ting KC, Eskin SG, Mikos AG. (1997). Microparticles of poly(dl-lactic-co-glycolide)/poly(ethylene glycol) blends for controlled drug delivery. J Control Release, 48:259–68.
   Web of Science ®Google Scholar
• Elvassore N, Bertucco A, Caliceti P. (2001). Production of insulin loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm Sci, 90:1628–36.
   PubMed Web of Science ®Google Scholar
• Hinds KD, Campbell KM, Holland KM, Lewis DH, Piche CA, Schmidt PG. (2005). PEGylated insulin in PLGA microparticles: In vivo and in vitro analysis. J Control Release, 104:447–60.
   PubMed Web of Science ®Google Scholar
• Yeh M, Jenkins PG, Davis SS, Coombes AGA. (1995). Improving the delivery capacity of microparticle systems using blends of poly(dl-lactide-co-glycolide) and poly(ethylene glycol). J Control Release, 37:1–9.
   Web of Science ®Google Scholar
• Wang J, Wang BM, Schwendeman SP. (2002). Characterization of the initial burst release of a model protein from poly(d,l-lactide-co-glycolide) microspheres. J Control Release, 82:289–307.
   PubMed Web of Science ®Google Scholar
• Fu K, Pack DW, Klibanov AM, Langer R. (2000). Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLA) microspheres. Pharm Res, 17:100–6.
   PubMed Web of Science ®Google Scholar
• Park TG, Lu W, Crotts G. (1995). Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(d, l-lactic acid-co-glycolic acid) microspheres. J Control Release, 33:211–22.
   Web of Science ®Google Scholar
• Pérez C, Castellanos IJ, Costantino HR, Al-Azzam W, Griebenow K. (2002). Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J Pharm Pharmacol, 54:301–13.
   PubMed Web of Science ®Google Scholar
• Weert MV, Hennink WE, Jiskoot W. (2000). Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res, 17:1159–67.
   PubMed Web of Science ®Google Scholar
• Yeh MK. (2000). The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. J Microencapsul, 17:743–56.
   PubMed Web of Science ®Google Scholar
• Manoharan C, Singh J. (2009). Insulin loaded PLGA microspheres: Effect of zinc salts on encapsulation, release, and stability. J Pharm Sci, 98:529–41.
   PubMed Web of Science ®Google Scholar
• Okochi H, Nakano M. (2000). Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv Drug Deliv Rev, 45:5–26.
   PubMed Web of Science ®Google Scholar
• Ravi S, Peh KK, Darwis Y, Murthy BK, Singh TRR. (2007). Development and validation of an HPLC–UV method for the determination of insulin in rat plasma: Application to pharmacokinetic study. Chromatographia, 66:805–9.
   Web of Science ®Google Scholar
• Hincal AA, Calis S. (2000). Microsphere preparation by solvent evaporation method. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology, New York: Marcel Decker Inc., 329–43.
   Google Scholar
• Ravi S, Peh KK, Darwis Y, Murthy BK, Singh TRR, Mallikarjun C. (2008). Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system. Ind J Pharm Sci, 70:303–9.
   PubMed Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng P. (2001). Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 22:231–41.
   PubMed Web of Science ®Google Scholar
• Kang F, Singh J. (2001). Effect of additives on the release of a model protein from PLGA microspheres. AAPS PharmSciTech, 2:1–7.
   Google Scholar
• Tracy MA. (1998). Development and scale–up of a microsphere protein delivery system. Biotechnol Prog, 14:108–15.
   PubMed Web of Science ®Google Scholar
• Scott DA. (1934). Crystalline insulin. Biochem. J, 28:1592–602.
   Google Scholar
• Jhonson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, . (1996). A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med, 2:795–9.
   PubMed Web of Science ®Google Scholar